Roche’s virtual analyst event during ESMO IO
Roche has hosted a virtual event on Friday, 10 December 2021.
Karl Mahler, Head of Investor Relations
- CITYSCAPE updated analysis: Tiragolumab + Tecentriq in 1L NSCLC
Raymond Meng, M.D., Ph.D. - Global Development Leader Tiragolumab
- Tiragolumab development overview
Heather Stevens, MBA, MPH - Life Cycle Leader, Tiragolumab
Please register to access the replay*